TCPG
CLB icon

Trivant Custom Portfolio Group’s Core Laboratories CLB Stock Holding History

Trivant Custom Portfolio Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-867
Closed -$20.8K – 207
2023
Q3 		$20.8K Sell
867
-1,256
-59% -$30.8K 0.02% 129
2023
Q2 		$49.4K Sell
2,123
-100
-4% -$2.26K 0.03% 105
2023
Q1 		$49K Buy
+2,223
New +$52K 0.04% 119

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Trivant Custom Portfolio Group's CLB Position: Q4 2023 in Review

Trivant Custom Portfolio Group sold out of Core Laboratories (CLB) in Q4 2023, closing a stake of 867 shares — an estimated $20.8K sold.

Trivant Custom Portfolio Group first reported a position in CLB in Q1 2023 and held it in 3 quarters. The position peaked at $49.4K in Q2 2023. 186 funds tracked by Wall St. Rank hold CLB as of Q4 2023.

  • Trivant Custom Portfolio Group reported no remaining Core Laboratories position as of Q4 2023 after selling out during the quarter.
  • Trivant Custom Portfolio Group sold 867 Core Laboratories shares in Q4 2023, an estimated $20.8K.
  • Trivant Custom Portfolio Group first reported a position in Core Laboratories in Q1 2023 and held it in 3 quarters.
  • Trivant Custom Portfolio Group's Core Laboratories position peaked at $49.4K in Q2 2023.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2023.

Based on Trivant Custom Portfolio Group's 13F filing for Q4 2023, filed 25 Jan 2024.